Den europeiske union -
norsk -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Den europeiske union -
norsk -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Norge -
norsk -
Statens legemiddelverk
pirfenidone sandoz 801 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg
Norge -
norsk -
Statens legemiddelverk
pirfenidone sandoz 267 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg
Norge -
norsk -
Statens legemiddelverk
pirfenidone newbury 267 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 267 mg
Norge -
norsk -
Statens legemiddelverk
pirfenidone newbury 801 mg
newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 801 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
ofev
boehringer ingelheim international gmbh - nintedanib - idiopatisk lungefibrose - antineoplastiske midler - ofev er indisert hos voksne til behandling av idiopatisk lungfibrose (ipf).
Den europeiske union -
norsk -
EMA (European Medicines Agency)
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunsuppressive - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.